Skip to main content
. 2014 Oct 15;74(17):2033–2051. doi: 10.1007/s40265-014-0306-5

Table 6.

Treatment algorithms [311]

Guidelines Patient characteristics Treatment recommendations
JNC 8 Patients categorised based on age, goal BP, race and patients with diabetes/CKD Specifies drug classes to be used as first-line treatment and longer-term follow-up treatment options if BP remains uncontrolled
ASH/ISH Patients categorised based on BP and other factors e.g., age, race, comorbidities Specifies drug class to be used as first-line treatment and longer-term follow-up treatment options if BP remains uncontrolled
AHA/ACC/CDC Patients categorised based on stage of hypertension Suggests drug classes to be used, monitoring and follow-up options
CHEP Provides algorithms for diagnosis and treatment Specifies drug classes to be used as first-line treatment and longer-term follow-up treatment options if BP remains uncontrolled
ESH/ESC Patients categorised based on low or high risk

Describes steps to be taken in moving to a more intensive therapy through dose titration or adding more drugs

No recommendations on drug classes or doses

France No algorithm provided n/a
NICE Diagnosis and treatment algorithms. Treatment algorithm categorised based on age and race Recommends drug classes to be used for initial therapy and drug combinations to be considered if BP remains uncontrolled
Taiwan Patients categorised based on BP and non-high risk or high risk Specifies the number of drugs to be prescribed but not specific drug classes or doses
China Patients categorised based on BP and risk assessment Specifies drug classes to be used as first-line treatment and longer-term follow-up treatment options if BP remains uncontrolled

AHA/ACC/CDC American Hypertension Association/American College of Cardiology/Centers for Disease Control and Prevention, ASH/ISH American Society of Hypertension/International Society of Hypertension, CHEP Canadian hypertension education program, ESH/ESC European Society of Hypertension/European Society of Cardiology, JNC 8 Eighth Joint National Committee, NICE National Institute for Clinical Excellence (UK), BP blood pressure, CKD chronic kidney disease, n/a not applicable